TR200003084T2 - Paroxetine ascorbate - Google Patents
Paroxetine ascorbateInfo
- Publication number
- TR200003084T2 TR200003084T2 TR2000/03084T TR200003084T TR200003084T2 TR 200003084 T2 TR200003084 T2 TR 200003084T2 TR 2000/03084 T TR2000/03084 T TR 2000/03084T TR 200003084 T TR200003084 T TR 200003084T TR 200003084 T2 TR200003084 T2 TR 200003084T2
- Authority
- TR
- Turkey
- Prior art keywords
- paroxetine ascorbate
- paroxetine
- ascorbate
- useful
- treatment
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 4
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 2
- 229940072107 ascorbate Drugs 0.000 title abstract 2
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 2
- 239000011668 ascorbic acid Substances 0.000 title abstract 2
- 229960002296 paroxetine Drugs 0.000 title abstract 2
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Paroxetine askorbat, bazi CNS hastaliklarinin tedavisinde faydalidir.Paroxetine ascorbate is useful in the treatment of some CNS diseases.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200003084T2 true TR200003084T2 (en) | 2001-02-21 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/03084T TR200003084T2 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (en) |
| JP (1) | JP2002513019A (en) |
| KR (1) | KR20010042977A (en) |
| CN (1) | CN1297448A (en) |
| AP (1) | AP2000001963A0 (en) |
| AU (1) | AU3618499A (en) |
| BG (1) | BG104940A (en) |
| BR (1) | BR9909868A (en) |
| CA (1) | CA2330055A1 (en) |
| EA (1) | EA200001104A1 (en) |
| GB (1) | GB9808896D0 (en) |
| HU (1) | HUP0102116A3 (en) |
| ID (2) | ID26083A (en) |
| IL (1) | IL139081A0 (en) |
| NO (1) | NO20005352L (en) |
| PL (1) | PL343677A1 (en) |
| SK (1) | SK15912000A3 (en) |
| TR (1) | TR200003084T2 (en) |
| WO (1) | WO1999055698A1 (en) |
| ZA (1) | ZA200005912B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| US7227033B2 (en) * | 2002-01-09 | 2007-06-05 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| CN118267895A (en) * | 2018-10-30 | 2024-07-02 | 中国科学院化学研究所 | Method for preparing drug or drug intermediate amorphous material |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| DE3688827T2 (en) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidine derivative, its manufacture and its use as a medicine. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (en) * | 1996-02-29 | 1999-07-01 | Ferrer Int | NEW PROCEDURE FOR OBTAINING (-) - TRANS -N-P-FLUOROBENZOILMETIL-4- (P-FLUOROFENIL) -3- ((3,4- (METHYLENDIOXI) PHENOXI) METHYL) -PIPERIDINE. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/en unknown
- 1999-04-23 ID IDW20002168A patent/ID26083A/en unknown
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/en not_active Withdrawn
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/en active Pending
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/en not_active Application Discontinuation
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Ceased
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/en unknown
- 1999-04-23 EA EA200001104A patent/EA200001104A1/en unknown
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/en unknown
- 1999-04-23 CN CN99805160A patent/CN1297448A/en active Pending
- 1999-04-23 ID IDW20002169A patent/ID26654A/en unknown
- 1999-04-23 IL IL13908199A patent/IL139081A0/en unknown
- 1999-04-23 PL PL99343677A patent/PL343677A1/en not_active Application Discontinuation
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352L/en not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ID26654A (en) | 2001-01-25 |
| EA200001104A1 (en) | 2001-04-23 |
| GB9808896D0 (en) | 1998-06-24 |
| ID26083A (en) | 2000-11-23 |
| CN1297448A (en) | 2001-05-30 |
| BG104940A (en) | 2001-09-28 |
| IL139081A0 (en) | 2001-11-25 |
| JP2002513019A (en) | 2002-05-08 |
| EP1089995A1 (en) | 2001-04-11 |
| CA2330055A1 (en) | 1999-11-04 |
| ZA200005912B (en) | 2001-12-19 |
| HUP0102116A2 (en) | 2002-05-29 |
| PL343677A1 (en) | 2001-08-27 |
| AP2000001963A0 (en) | 2000-12-31 |
| HUP0102116A3 (en) | 2002-12-28 |
| WO1999055698A1 (en) | 1999-11-04 |
| NO20005352D0 (en) | 2000-10-24 |
| SK15912000A3 (en) | 2001-04-09 |
| KR20010042977A (en) | 2001-05-25 |
| BR9909868A (en) | 2000-12-19 |
| AU3618499A (en) | 1999-11-16 |
| NO20005352L (en) | 2000-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60022692D1 (en) | (S, S) reboxetine for the treatment of migraine headache | |
| TR200000059T2 (en) | Pyridine derivatives | |
| ID26043A (en) | 1,2,5-TRIAZINA TRITIZED SUBSTITUTIONS FOR TREATMENT OF HIV INFECTIONS | |
| DE60010098D1 (en) | 28-EPIRAPALOGE | |
| DE69925306D1 (en) | TREATMENT OF HYDROCARBONGAS | |
| PT1140944E (en) | EPOTILONE DERIVATIVES AND THEIR USE AS ANTITUMATIC AGENTS | |
| ATE350044T1 (en) | THROMBOPOIETIN MIMETICS | |
| BR9707233A (en) | Phenanthridines | |
| ES2184077T3 (en) | NEW FENANTRIDINS REPLACED IN POSITION 6. | |
| CO4970820A1 (en) | BISULPHATE SALT OF HIV-PROTEASE INHIBITOR | |
| CY1108610T1 (en) | IL-2 Peptides and their derivatives and their use as therapeutic agents | |
| ATE315934T1 (en) | THROMBOPOIETIN MIMETICS | |
| ATE274348T1 (en) | BRIDGED INDENOPYRROLOCARBAZOLES | |
| DE60139466D1 (en) | TREATMENT OF DIABETES | |
| DE60115466D1 (en) | ACTIVE PROCESSORS OF IMIDAZOPYRIDINE DERIVATIVES | |
| PT1204659E (en) | SEROTONINERGIC BENZOFURANOS | |
| CY1107039T1 (en) | TRIPEPTIDYL PEPTIDASE Suspensions | |
| TR200200278T2 (en) | Calcilitic compositions | |
| TR200003084T2 (en) | Paroxetine ascorbate | |
| NO20005548D0 (en) | Mykobakterieinhibitorer | |
| TR200002939T2 (en) | Paroxetine maleate | |
| ES2185605T3 (en) | 2,3-DIHIDRO-1H-5,9-DIOXACICLOHEPTA (F) INDEN-7-WAVES 1,2-SUBSTITUTES AND BENZO (B) (1,4) DIOXEPIN-3 WAVES 7-REPLACED. | |
| TR200003083T2 (en) | Paroxetine 10-camphorsulfonate for the treatment of CNS diseases. | |
| NO20021429D0 (en) | 1,4-dioxacycloalkan-2-one and 1,4-dioxacycloalken-2-one | |
| PT1017377E (en) | UTILIZATION OF 6,7-SUBSTITUTED 2-AMINOTETRALINS FOR THE TREATMENT OF CYLOCHINE-MEDIATED INFLAMMATORY CONDITIONS |